# NHS National Pharmaceuticals Transition 2021\_2 - Pemetrexed LSNE

> Contract award record from UK public-sector procurement sources.

## Key facts

- Public buyer: [NHS England](/buyers/nhs-england/contract-awards)
- Contract winner: Mylan
- Award value: £1,520
- Tender value: £1,520
- Award date: 17 June 2021
- Published: 14 July 2021
- Contract start: 24 June 2021
- Contract end: 31 January 2023
- Stage: awarded
- Procurement category: goods
- Notice ID: 91f4ed0b-4e63-4d29-9f3b-dcafca78bdf8-451329
- OCID: ocds-b5fd17-50f66811-fc34-4a5c-a6ba-6d48c9386892

## Description

Offer reference number: CM/PHG/21/5639/00 Period of framework agreement: The total maximum duration of the framework agreement to be no more than 38 months \(19 months plus options to extend \(at the Authority's sole discretion\) for up to a further 19 months\) Potential periods of call-offs under the framework agreement: 24/06/2021 to 31/01/2023 \(19 months\) LSNE region\.

## Related contract awards

- [Transformation Delivery Services - Establishing Operational Excellence \(EOE\)](/contracts/ocds-b5fd17-b08595d2-8961-409b-9b62-7b01d7a64541): NHS England
- [Identity Access Management - Service Adoption and Enablement](/contracts/ocds-b5fd17-08ebad6c-84fb-4e62-9afd-d06d220dd3a5): NHS England
- [OutSystems licenses for MAPPTI \(AP&P\)](/contracts/ocds-b5fd17-521fbf90-6e93-4366-b3bc-47aa2efd447d): NHS England
- [NHS Framework Agreement for South of England Branded - Tranche B and Annual](/contracts/ocds-b5fd17-4c9013e7-bbb5-4254-b8ad-705ccb4e5887): NHS England
- [NHS National Generic Pharmaceuticals - Clozapine](/contracts/ocds-b5fd17-1a206321-9cf2-47a6-98e6-fcc05ff101ee): NHS England
- [NHS Framework Agreement for Glatiramer acetate injection - North of England](/contracts/ocds-b5fd17-ed6126f2-1b57-433b-a8db-a858839857f8): NHS England

## Source

[View the original notice on Contracts Finder](https://www.contractsfinder.service.gov.uk/Notice/91f4ed0b-4e63-4d29-9f3b-dcafca78bdf8-451329)